Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical laboratory analysis"
DOI: 10.1002/jcla.24277
Abstract: BACKGROUND Lung adenocarcinoma (LUAD) is a lung cancer subtype with poor prognosis. We investigated the prognostic value of methylation- and homologous recombination deficiency (HRD)-associated gene signatures in LUAD. METHODS Data on RNA sequencing, somatic mutations,… read more here.
Keywords: lung; methylation; prognosis; methylation homologous ... See more keywords